Over the weekend, Atrium Innovations announced its pending acquisition by a consortium of investors led by Permira, a European private-equity bank with C$30 billion in assets under management. The deal values Atrium at C$24 per share, a premium of 23% over the previous day's trading price. Post-close, Permira would own 75% of the nutrition and health products company, with two long-term minority shareholders--the Fond and the Caisse--splittin
Atrium Innovations in play?
Permira, the Fonds, the Caisse offer $24 per share for leading supplements rollup